ABT Abbott Stock Outlook 2026: FreeStyle Libre's CGM Moat Is Widening While Dexcom Struggles
Abbott Laboratories (ABT) stock outlook 2026. FreeStyle Libre CGM dominance, 4-segment diversification, 52-year dividend streak, 50% analyst upside, and price target scenarios for US investors.
ABT Abbott FreeStyle Libre